Polycystic ovary syndrome (PCOS) is an inherited disease that affects women of childbearing age. The disorder causes multiple abnormal cysts in enlarged ovaries, so that they do not produce the normal number of eggs and do not ovulate (release eggs) normally. The disease is present at birth but does not cause symptoms until women enter puberty. PCOS occurs in up to 10% of women and is a leading cause of female infertility. Women with PCOS have irregular and infrequent menstrual periods and may develop amenorrhea (complete absence of menstrual periods). Women with PCOS are likely to have high blood pressure, obesity (especially central obesity, around the midsection of the abdomen), facial acne, hirsutism (excessive facial and body hair growth), and thinning scalp hair. They also have insulin resistance, which may lead to development of type 2 diabetes. The February 7, 2007, issue of JAMA includes an article about polycystic ovary syndrome.
Grahic Jump Location
History of irregular or absent menstrual periods
Ultrasound examination of the ovaries (looking for the presence of multiple cysts)
Blood pressure checks (since the risk of high blood pressure is high in women with PCOS)
Screening for diabetes because women who have PCOS are likely to develop glucose intolerance (elevated glucose levels on an oral glucose tolerance test) and type 2 diabetes
Treatment of PCOS focuses on the symptoms that occur in each individual. Risk reduction for diabetes and heart disease is important. A number of treatments are available:
Weight loss and exercise can help to manage diabetes and high blood pressure and reduce risk of development of cardiovascular disease and stroke. Weight loss and exercise are also crucial to prevent type 2 diabetes. Medications may be prescribed to control blood pressure.
Stopping smoking reduces risk of cardiac disease.
Treating type 2 diabetes may involve oral medications and insulin if diet and exercise do not control elevated blood sugar levels.
Oral contraceptives (birth control pills) regulate menstrual periods and suppress androgen (the hormone that causes excess body and facial hair growth in women).
Metformin, an oral medication often used in treating type 2 diabetes, improves insulin resistance even if diabetes is not yet present, decreases androgen, and improves ovulation.
Spironolactone is a diuretic that decreases androgen and treats acne and hirsutism.
Mechanical methods (plucking, shaving, depilatory products) help to manage excessive hair growth. Laser treatments and prescription creams may also be prescribed for women with hirsutism.
American College of Obstetricians and Gynecologistshttp://www.acog.org
Polycystic Ovarian Syndrome Association 877/775-PCOShttp://www.pcosupport.org
To find this and previous JAMA Patient Pages, go to the Patient Page Index on JAMA's Web site at http://www.jama.com. Many are available in English and Spanish. A Patient Page on weight and diabetes was published in the March 15, 2006, issue.
Sources: American College of Obstetricians and Gynecologists; Polycystic Ovarian Syndrome Association; American Academy of Family Physicians
The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 203/259-8724.
TOPIC: WOMEN'S HEALTH
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.